Medistim ASA (MEDI) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.098x

Based on the latest financial reports, Medistim ASA (MEDI) has a cash flow conversion efficiency ratio of 0.098x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr37.65 Million ≈ $3.96 Million USD) by net assets (Nkr383.81 Million ≈ $40.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medistim ASA - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Medistim ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medistim ASA balance sheet liabilities for a breakdown of total debt and financial obligations.

Medistim ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medistim ASA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kyverna Therapeutics, Inc. Common Stock NASDAQ:KYTX	-0.285x
Wave Cyber Shanghai Co Ltd SHG:688718	0.028x
Smcp SAS PA:SMCP	0.110x
Youlchon Chem KO:008730	0.029x
Laxmi Organic Industries Limited NSE:LXCHEM	0.029x
Vishnu Chemicals Limited NSE:VISHNU	0.091x
Chaun-Choung Technology Corp TW:6230	-0.036x
Sofwave Medical Ltd TA:SOFW	0.097x

Annual Cash Flow Conversion Efficiency for Medistim ASA (2004–2024)

The table below shows the annual cash flow conversion efficiency of Medistim ASA from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Medistim ASA (MEDI) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr436.61 Million ≈ $45.94 Million	Nkr143.10 Million ≈ $15.06 Million	0.328x	+15.23%
2023-12-31	Nkr397.94 Million ≈ $41.87 Million	Nkr113.19 Million ≈ $11.91 Million	0.284x	-8.70%
2022-12-31	Nkr367.69 Million ≈ $38.69 Million	Nkr114.56 Million ≈ $12.05 Million	0.312x	-25.59%
2021-12-31	Nkr306.05 Million ≈ $32.21 Million	Nkr128.14 Million ≈ $13.48 Million	0.419x	+45.06%
2020-12-31	Nkr256.85 Million ≈ $27.03 Million	Nkr74.13 Million ≈ $7.80 Million	0.289x	-14.95%
2019-12-31	Nkr236.86 Million ≈ $24.92 Million	Nkr80.38 Million ≈ $8.46 Million	0.339x	+25.73%
2018-12-31	Nkr206.71 Million ≈ $21.75 Million	Nkr55.79 Million ≈ $5.87 Million	0.270x	-17.83%
2017-12-31	Nkr182.98 Million ≈ $19.26 Million	Nkr60.10 Million ≈ $6.32 Million	0.328x	+79.69%
2016-12-31	Nkr166.70 Million ≈ $17.54 Million	Nkr30.47 Million ≈ $3.21 Million	0.183x	-36.08%
2015-12-31	Nkr156.16 Million ≈ $16.43 Million	Nkr44.66 Million ≈ $4.70 Million	0.286x	-18.72%
2014-12-31	Nkr139.10 Million ≈ $14.64 Million	Nkr48.94 Million ≈ $5.15 Million	0.352x	+64.32%
2013-12-31	Nkr121.64 Million ≈ $12.80 Million	Nkr26.04 Million ≈ $2.74 Million	0.214x	-6.06%
2012-12-31	Nkr115.17 Million ≈ $12.12 Million	Nkr26.25 Million ≈ $2.76 Million	0.228x	-1.22%
2011-12-31	Nkr106.89 Million ≈ $11.25 Million	Nkr24.66 Million ≈ $2.60 Million	0.231x	-33.24%
2010-12-31	Nkr107.83 Million ≈ $11.35 Million	Nkr37.27 Million ≈ $3.92 Million	0.346x	+12.06%
2009-12-31	Nkr106.29 Million ≈ $11.19 Million	Nkr32.78 Million ≈ $3.45 Million	0.308x	+10.02%
2008-12-31	Nkr95.46 Million ≈ $10.05 Million	Nkr26.76 Million ≈ $2.82 Million	0.280x	+26.46%
2007-12-31	Nkr93.83 Million ≈ $9.87 Million	Nkr20.80 Million ≈ $2.19 Million	0.222x	-5.17%
2006-12-31	Nkr74.06 Million ≈ $7.79 Million	Nkr17.31 Million ≈ $1.82 Million	0.234x	+5.83%
2005-12-31	Nkr67.41 Million ≈ $7.09 Million	Nkr14.89 Million ≈ $1.57 Million	0.221x	+152.67%
2004-12-31	Nkr61.71 Million ≈ $6.49 Million	Nkr5.39 Million ≈ $567.71K	0.087x	--

About Medistim ASA

OL:MEDI Norway Medical Devices

Market Cap

$432.64 Million

Nkr4.11 Billion NOK

Market Cap Rank

#13308 Global

#100 in Norway

Share Price

Nkr225.00

Change (1 day)

-1.32%

52-Week Range

Nkr165.00 - Nkr284.00

All Time High

Nkr377.47